We recently published a list of Jim Cramer’s Thoughts on These 10 Stocks. In this article, we are going to take a look at ...

Biohaven Ltd. (NYSE:BHVN) has announced major breakthroughs with its novel precision immunology therapies, BHV-1400 and ...

Biohaven (NYSE:BHVN) stock gains on tumor-shrinking results for the company's cancer drug BHV-1510 with Regeneron's (REGN) ...

During the lightning round, a caller asked about Biohaven Ltd. (NYSE:BHVN), and Cramer commented: “Alright, Biohaven had an analyst day the other day, and it was, you know, people didn’t get ...

Biohaven Pharmaceutical BHVN and Pfizer PFE announced a definitive agreement wherein the latter will acquire the former for $148.50 per share or an aggregate equity value of $11.6 billion.

In a report released today, Tyler Van Buren from TD Cowen maintained a Buy rating on Biohaven Ltd. (BHVN – Research Report), with a price target of $75.00. The company’s share ...

BHVN’s lead asset is Troriluzole, which is nearing a pivotal FDA decision by August 2025. The company also recently secured an additional $600 million financing through secured notes with ...

Investors in Biohaven Ltd (Symbol: BHVN) saw new options become available this week, for the October 17th expiration. One of the key data points that goes into the price an option buyer is willing ...

Investors in Biohaven Pharmaceutical Holding Co Ltd (Symbol: BHVN) saw new options become available this week, for the June 17th expiration. At Stock Options Channel, our YieldBoost formula has ...